IP Library › Granted Patent US 7,569,667
Granted Patent B2
US 7,569,667 · App. 11/429,115 · Granted Aug 4, 2009

Isolated soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof

Assignee: Wyeth
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,569,667
App. No.
11/429,115
Granted
Aug 4, 2009
Kind
B2
Abstract

The invention relates to soluble proteins which bind to the molecule known as IL-TIF/IL-22. The proteins can antagonize the effect of IL-TIF/IL-22 on target cells. The nucleic acid molecules encoding the proteins, and uses of the protein, are also described.

Claims (3)

1. An isolated, soluble binding protein which binds to IL-TIF/IL-22, wherein the isolated soluble binding protein comprises the amino acid sequence set forth at SEQ ID NO: 11.

2. The isolated, soluble binding protein of claim 1 , further comprising a detectable label.

3. The isolated, soluble binding protein of claim 1 , wherein said soluble binding protein is an antagonist for IL-TIF/IL-22.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2007
From: LUDWIG INSTITUTE FOR CANCER RESEARCH
To: WYETH
Reel/Frame 018907/0819 →
Continuity (6)
Division 1038558600 · Mar 11, 2003
Continuation PCTUS012957600 · Sep 21, 2001
Continuation 0991916200 · Jul 31, 2001
Provisional Application 6024549500 · Nov 3, 2000
Provisional Application 6023458300 · Sep 22, 2000
Related Publication 20070104681A1 · May 10, 2007